Editorial reply.
Seidman
Stuart N
SN
Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York State Psychiatric Institute, New York, New York, USA. sns5@columbia.edu
D015510:Clinical Medicine / Q000458:organization & administration; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D012107:Research Design; D044347:Sexology / Q000458:organization & administration*; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy / Q000628:therapy*; D020018:Sexual Dysfunctions, Psychological / Q000188:drug therapy / Q000628:therapy*; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use; D016896:Treatment Outcome; D014481:United States; D014665:Vasodilator Agents / Q000627:therapeutic use
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate